StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$96.32−2.92 (-2.94%)

Close on Nov 17, 2026Market cap $6.38BP/E –Yield –

Earnings

Oruka Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2024
–
EPS, Q2 FY2024
-$0.18
-$0.10 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Oruka Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 10, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026Apr 30, 2026after the close–––Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024after the close––-$0.18Release
Q1 FY2024ended Mar 31, 2024Apr 25, 2024after the close––-$0.14Release
Q4 FY2023ended Dec 31, 2023Feb 1, 2024after the close–––Release
Q3 FY2023ended Sep 30, 2023Oct 18, 2023after the close––-$0.10Release
Q2 FY2023ended Jun 30, 2023Jul 21, 2023after the close––-$0.10Release
Q1 FY2023ended Mar 31, 2023Apr 24, 2023after the close––-$0.09Release
Q4 FY2022ended Dec 31, 2022Feb 24, 2023after the close–––Release
Q3 FY2022ended Sep 30, 2022Oct 28, 2022after the close––-$0.16Release
Q2 FY2022ended Jun 30, 2022Aug 2, 2022after the close––-$0.22Release
Q1 FY2022ended Mar 31, 2022May 2, 2022after the close––-$0.23Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Oruka Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Oruka Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Oruka Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Results
  4. Results
  5. Update
  6. Update
  7. Update
  8. Update
  9. News
  10. Update
  11. Update
  12. Results
  13. Results
  14. Results
  15. News

See a number that looks wrong?